| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $1.2M | -48.2% | +17.8% |
| SG&A Expense | $1.3M | -27.4% | -17.2% |
| Operating Income | -$2.5M | +39.1% | +79.6% |
| Pre-tax Income | -$2.8M | -20.9% | +76.6% |
| Income Tax | $0 | — | +100.0% |
| Net Income | -$2.8M | -20.9% | +75.8% |
| EPS (Basic) | -$0.19 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $16.9M | -5.1% | — |
| Current Assets | $20.5M | -2.0% | +0.5% |
| Total Assets | $20.8M | -1.9% | +2.1% |
| Current Liabilities | $8.8M | -2.8% | +18.5% |
| Total Liabilities | $8.8M | -2.8% | +18.5% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$11.6M | — | — |
| Financing Cash Flow | $10.9M | — | — |
| -26.7% |
| +97.5% |
| $12.0M |
| -1.3% |
| -7.4% |